For the Inventor, By the Inventor

Enter assignee name

Kumamoto, Japan

Km Biologics Co., Ltd.

USPTO Granted Patents = 24

% Expired Patents = 4.2

CIPO Patents = 3

EPO Patents = 22

Trademarks = 1

Forward Citations = 5

Loading Chart...

Loading Chart...

95 inventors (with patents filed for the assignee):

Masaharu Torikai (7 out of 13 patents)

Hiroaki Mori (6 out of 6 patents)

Hiroyuki Shimizu (6 out of 71 patents)

4. Tomohiro Nishimura (5 out of 5 patents)

5. Kenji Soejima (4 out of 17 patents)

6. Miyuki Matsumoto (4 out of 4 patents)

7. Toshihiro Nakashima (4 out of 20 patents)

8. Akihiro Koube (3 out of 3 patents)

9. Akihiko Hosoi (3 out of 3 patents)

10. Tomoyo Takeo (3 out of 3 patents)

11. Masayo Ueno (3 out of 3 patents)

12. Yukio Ando (3 out of 4 patents)

13. Hirofumi Jono (3 out of 4 patents)

14. Yu Su (3 out of 4 patents)

15. Motoharu Abe (3 out of 3 patents)

24 patents: Sort by Forward Citations

1. 12290560 - Vaccine for preventing or treating congenital infection with cytomegalovirus (2025-05-06),

2. 12268738 - Liquid six combined vaccine composition (2025-04-08),

3. 12220457 - Modified CMV gB protein and CMV vaccine including same (2025-02-11),

4. 12121578 - RSV F/G chimeric vaccine (2024-10-22),

5. 11957325 - Biological tissue adhesive nebulizer and clogging prevention container (2024-04-16),

6. 11952398 - Chromatographic method for collecting blood coagulation factor VII with high yield (2024-04-09),

7. 11567080 - Diagnostic agent and medicine comprising ADAMTS13 as main ingredient (2023-01-31),

8. 11472867 - Anti-HSV GB monoclonal antibody or antigen-binding fragment thereof (2022-10-18),

9. 11433160 - Formed sheet product and hemostatic material (2022-09-06),

10. 11421002 - Modified HSV gB protein and HSV vaccine including same (2022-08-23),

11. 11357847 - Modified HSV gD protein and vaccine containing same (2022-06-14),

12. 11186630 - Anti-transthyretin human antibody (2021-11-30),

13. 11059857 - Chromatographic method for collecting blood coagulation factor VII with high yield (2021-07-13),

14. 11027005 - Method for producing Hib conjugate vaccine using PRP with lowered molecular weight (2021-06-08),

15. 10881723 - Vaccine containing immobilized virus particles (2021-01-05),

KM Biologics Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative biological products. With a focus on improving human health, KM Biologics is dedicated to providing high-quality solutions in areas such as diagnostics, therapeutics, and vaccines. Our team of experienced scientists and researchers work tirelessly to create cutting-edge solutions that address some of the most pressing healthcare challenges. Visit our website to learn more about our products and ongoing research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 8 2026

24 Patents

#6 in Kumamoto

#2,628 in Japan

#26,532 in the World

Kumamoto, Japan

Km Biologics Co., Ltd.

Forward Citations = 5

95 inventors:

Masaharu Torikai (7 out of 13 patents)

Hiroaki Mori (6 out of 6 patents)

Hiroyuki Shimizu (6 out of 71 patents)

4. Tomohiro Nishimura (5 out of 5 patents)

5. Kenji Soejima (4 out of 17 patents)

Please report any incorrect information to [email protected]

Loading…